Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000232582 | SCV000287101 | likely benign | Primary ciliary dyskinesia | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000667515 | SCV000791983 | uncertain significance | Primary ciliary dyskinesia 3 | 2017-06-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000232582 | SCV004050841 | likely benign | Primary ciliary dyskinesia | 2023-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000232582 | SCV001452459 | uncertain significance | Primary ciliary dyskinesia | 2020-01-10 | no assertion criteria provided | clinical testing |